Revenue
2023
2024
2025
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | $2.3M | $2.0M | $119,534 |
| Research & development | $9.0M | $0 | — |
| Operating expenses | $12.1M | $1.0M | $1.3M |
| Operating income | −$9.8M | $982,640 | −$1.1M |
| Operating margin | −418.90% | 48.42% | −949.10% |
| EBITDA | −$9.7M | $991,215 | −$1.1M |
| EBITDA margin | −418.55% | 48.85% | −947.53% |
| Net income | −$9.6M | $866,769 | −$981,838 |
| Net profit margin | −411.82% | 42.71% | −821.39% |
| Basic EPSper basic share | -$1.65 | $0.22 | -$0.24 |
| Diluted EPSper diluted share | -$1.65 | $0.22 | -$0.24 |
Reported shareholders
Reported holdings Number of shares
| Holder | Shares held |
|---|---|
Qian Fenglei | 4M |
HRT FINANCIAL LP | 47.59K |
XTX Topco Ltd | 23.71K |
NOMURA HOLDINGS INC | 10.03K |
UBS Group AG | 2.26K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.